Fulton Breakefield Broenniman’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
622
+148
| +31% | +$60K | 0.02% | 170 |
|
|
2025
Q1 | $236K | Sell |
474
-11
| -2% | -$5.47K | 0.02% | 163 |
|
|
2024
Q4 | $252K | Hold |
485
| – | – | 0.02% | 161 |
|
|
2024
Q3 | $300K | Sell |
485
-183
| -27% | -$113K | 0.02% | 145 |
|
|
2024
Q2 | $369K | Sell |
668
-8
| -1% | -$4.42K | 0.03% | 130 |
|
|
2024
Q1 | $393K | Hold |
676
| – | – | 0.03% | 126 |
|
|
2023
Q4 | $359K | Sell |
676
-148
| -18% | -$78.5K | 0.03% | 129 |
|
|
2023
Q3 | $417K | Hold |
824
| – | – | 0.04% | 117 |
|
|
2023
Q2 | $430K | Sell |
824
-3
| -0.4% | -$1.56K | 0.04% | 121 |
|
|
2023
Q1 | $476K | Buy |
827
+4
| +0.5% | +$2.3K | 0.04% | 114 |
|
|
2022
Q4 | $453K | Hold |
823
| – | – | 0.04% | 117 |
|
|
2022
Q3 | $417K | Buy |
823
+1
| +0.1% | +$507 | 0.04% | 111 |
|
|
2022
Q2 | $447K | Buy |
822
+11
| +1% | +$5.98K | 0.04% | 116 |
|
|
2022
Q1 | $479K | Sell |
811
-10
| -1% | -$5.91K | 0.04% | 104 |
|
|
2021
Q4 | $547K | Buy |
+821
| New | +$547K | 0.04% | 116 |
|